Upregulation of prostaglandin E2 and matrix metalloproteinase 9 production by human macrophage-like cells: Synergistic effect of capsular material and cell wall from Streptococcus suis

MacInnes, 1999, Agents of the ‘suis-ide diseases’ of swine: Actinobacillus suis, Haemophilus parasuis, and Streptococcus suis, Can J Vet Res, 63, 83 Gottschalk, 2000, The pathogenesis of the meningitis caused by Streptococcus suis: the unresolved questions, Vet Microbiol, 76, 259, 10.1016/S0378-1135(00)00250-9 Tarradas, 2001, Epidemiological relationship of human and swine Streptococcus suis isolates, J Vet Med B Infect Dis Vet Public Health, 48, 347, 10.1046/j.1439-0450.2001.00460.x Segura, 2004, Extracellular virulence factors of streptococci associated with animal diseases, Front Biosci, 9, 1157, 10.2741/1287 Smith, 1999, Identification and characterization of the cps locus of Streptococcus suis serotype 2: the capsule protects against phagocytosis and is an important virulence factor, Infect Immun, 67, 1750, 10.1128/IAI.67.4.1750-1756.1999 Jaworowicz, 1998, Nitric oxide and prostaglandin E2 formation parallels blood-brain barrier disruption in an experimental rat model of bacterial meningitis, Brain Res Bull, 46, 541, 10.1016/S0361-9230(98)00052-5 Paul, 1998, Matrix metalloproteinases contribute to the blood–brain barrier disruption during bacterial meningitis, Ann Neurol, 44, 592, 10.1002/ana.410440404 Rosenberg, 2002, Matrix metalloproteinases in neuroinflammation, Glia, 39, 279, 10.1002/glia.10108 Leib, 2000, Matrix metalloproteinases contribute to brain damage in experimental pneumococcal meningitis, Infect Immun, 68, 615, 10.1128/IAI.68.2.615-620.2000 Harris, 2002, Prostaglandins as modulators of immunity, Trends Immunol, 23, 144, 10.1016/S1471-4906(01)02154-8 Segura, 2002, Streptococcus suis interactions with the murine macrophage cell line J774: adhesion and cytotoxicity, Infect Immun, 70, 4312, 10.1128/IAI.70.8.4312-4322.2002 Segura, 2004, Encapsulated Streptococcus suis inhibits activation of signaling pathways involved in phagocytosis, Infect Immun, 72, 5322, 10.1128/IAI.72.9.5322-5330.2004 Segura, 1999, Heat-killed Streptococcus suis capsular type 2 strains stimulate tumor necrosis factor alpha and interleukin-6 production by murine macrophages, Infect Immun, 67, 4646, 10.1128/IAI.67.9.4646-4654.1999 Segura, 2002, CD14-dependent and -independent cytokine and chemokine production by human THP-1 monocytes stimulated by Streptococcus suis capsular type 2, Clin Exp Immunol, 127, 243, 10.1046/j.1365-2249.2002.01768.x Ueda, 1995, Role of prostaglandin in the formation of osteoclasts induced by capsular-like polysaccharide antigen of Actinobacillus actinomycetemcomitans strain Y4, Oral Microbiol Immunol, 10, 69, 10.1111/j.1399-302X.1995.tb00121.x Aronoff, 2004, Prostaglandin E2 inhibits alveolar macrophage phagocytosis through an E-prostanoid 2 receptor-mediated increase in intracellular cyclic AMP1,2, J Immunol, 173, 559, 10.4049/jimmunol.173.1.559 Tilley, 2001, Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes, J Clin Invest, 108, 15, 10.1172/JCI200113416 Tenenbaum, 2005, Strain-dependent disruption of blood-cerebrospinal fluid barrier by Streptoccocus suis in vitro, FEMS Immunol Med Microbiol, 44, 25, 10.1016/j.femsim.2004.12.006 Leppert, 2000, Matrix metalloproteinase (MMP)-8 and MMP-9 in cerebrospinal fluid during bacterial meningitis: association with blood–brain barrier damage and neurological sequelae, Clin Infect Dis, 31, 80, 10.1086/313922 Azeh, 1998, Experimental pneumococcal meningitis in rabbits: the increase of matrix metalloproteinase-9 in cerebrospinal fluid correlates with leucocyte invasion, Neurosci Lett, 256, 127, 10.1016/S0304-3940(98)00776-9 Kim, 2005, Chlamydia pneumoniae enhances cytokine-stimulated human monocyte matrix metalloproteinases through a prostaglandin E2-dependent mechanism, Infect Immun, 73, 632, 10.1128/IAI.73.1.632-634.2005 Khan, 2004, Extracellular matrix-induced cyclooxygenase-2 regulates macrophage proteinase expression, J Biol Chem, 279, 22039, 10.1074/jbc.M312735200 Leemans, 2003, Lipoteichoic acid and peptidoglycan from Staphylococcus aureus synergistically induce neutrophil influx into the lungs of mice, Clin Diagn Lab Immunol, 10, 950, 10.1128/CDLI.10.5.950-953.2003 De Kimpe, 1995, The cell wall components peptidoglycan and lipoteichoic acid from Staphylococcus aureus act in synergy to cause shock and multiple organ failure, Proc Natl Acad Sci USA, 92, 10359, 10.1073/pnas.92.22.10359 Jiang, 2003, The synergistic effect of peptidoglycan and lipopolysaccaride on osteoclast formation, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 96, 738, 10.1016/j.tripleo.2003.08.006 Wang, 2001, Peptidoglycan primes for LPS-induced release of proinflammatory cytokines in whole human blood, Shock, 16, 178, 10.1097/00024382-200116030-00002 del Campo Sepulveda, 1996, Detection of antibodies against Streptococcus suis capsular type 2 using a purified capsular polysaccharide antigen-based indirect ELISA, Vet Microbiol, 52, 113, 10.1016/0378-1135(96)00056-9 Rovera, 1979, Human promyelocytic leukemia cells in culture differentiate into macrophage-like cells when treated with a phorbol diester, Proc Natl Acad Sci USA, 76, 2779, 10.1073/pnas.76.6.2779